2000
DOI: 10.1097/00063198-200011000-00014
|View full text |Cite
|
Sign up to set email alerts
|

Allergic bronchopulmonary aspergillosis in cystic fibrosis

Abstract: The current standards of care for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis are presented. Recent studies have increased understanding of the inflammatory process that occurs in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. This has resulted in more precise diagnostic criteria that facilitate more timely diagnosis and treatment of ABPA in these patients. In addition to traditional treatment with systemic corticosteroids, promising results have been docume… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2002
2002
2011
2011

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 23 publications
0
10
0
Order By: Relevance
“…Among them, Aspergillus fumigatus has been reported with a prevalence ranging from 16 to 45.7% in CF patients (2,3,7,8,18). This fungus is well known to clinicians involved in the follow-up of these patients since it may cause various diseases, the most common being allergic bronchopulmonary aspergillosis (3,12,26,43). In addition, other Aspergillus species, including Aspergillus flavus and Aspergillus niger, may be present as transient colonizers of the airways, usually without any associated clinical signs (28,38).…”
mentioning
confidence: 99%
“…Among them, Aspergillus fumigatus has been reported with a prevalence ranging from 16 to 45.7% in CF patients (2,3,7,8,18). This fungus is well known to clinicians involved in the follow-up of these patients since it may cause various diseases, the most common being allergic bronchopulmonary aspergillosis (3,12,26,43). In addition, other Aspergillus species, including Aspergillus flavus and Aspergillus niger, may be present as transient colonizers of the airways, usually without any associated clinical signs (28,38).…”
mentioning
confidence: 99%
“…In patients with baseline high IgE level, a 2-fold rise in IgE may antedate an ABPA flare. Reduction in IgE by 50% after high-dose systemic corticosteroid therapy also supports the diagnosis [5]. Recent work suggests that a limited panel of recombinant allergens, used either for skin tests or as the antigen in RAST testing, improve specificity for the detection of sensitization to A. fumigatus, as well as for the detection of ABPA [16,17].…”
Section: Clinical Features and Diagnostic Criteria For Abpa In Cfmentioning
confidence: 84%
“…Ideally corticosteroid therapy should be withdrawn in 2-3 months. If there is no improvement, the diagnosis of ABPA [5] should be questioned. If the patient relapses during the corticosteroid taper, corticosteroid dosages should be increased and/or itraconazole added.…”
Section: Treatment Of Abpa In Cf Patientsmentioning
confidence: 99%
See 2 more Smart Citations